Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.
about
Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentanPrevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structureThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesCYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction.Translational issues with the development of cognition enhancing drugs
P2860
Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.
@en
type
label
Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.
@en
prefLabel
Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.
@en
P2093
P2860
P1476
Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.
@en
P2093
Gérald Simonneau
Marie-Camille Chaumais
Olivier Sitbon
Swanny Perrin
P2860
P304
P356
10.1517/17425255.2013.804063
P407
P577
2013-06-12T00:00:00Z